A phase II study of ibrutinib in combination with rituximab-cyclophosphamide-doxorubicin hydrochloride-vincristine sulfate-prednisone therapy in Epstein-Barr virus-positive, diffuse large B cell lymphoma (54179060LYM2003: IVORY study): results of the final analysis
Titel:
A phase II study of ibrutinib in combination with rituximab-cyclophosphamide-doxorubicin hydrochloride-vincristine sulfate-prednisone therapy in Epstein-Barr virus-positive, diffuse large B cell lymphoma (54179060LYM2003: IVORY study): results of the final analysis
Auteur:
Yoon, Sang Eun Kim, Seok Jin Yoon, Dok Hyun Koh, Youngil Mun, Yeung-Chul Do, Young Rok Choi, Yoon Seok Yang, Deok Hwan Kim, Min Kyoung Lee, Gyeong-Won Suh, Cheolwon Ko, Young Hyeh Kim, Won Seog